Icilio Cavero

5.8k total citations
193 papers, 4.8k citations indexed

About

Icilio Cavero is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Icilio Cavero has authored 193 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 71 papers in Cardiology and Cardiovascular Medicine and 52 papers in Physiology. Recurrent topics in Icilio Cavero's work include Receptor Mechanisms and Signaling (52 papers), Cardiac electrophysiology and arrhythmias (43 papers) and Nitric Oxide and Endothelin Effects (39 papers). Icilio Cavero is often cited by papers focused on Receptor Mechanisms and Signaling (52 papers), Cardiac electrophysiology and arrhythmias (43 papers) and Nitric Oxide and Endothelin Effects (39 papers). Icilio Cavero collaborates with scholars based in France, United States and Italy. Icilio Cavero's co-authors include Alan G. Roach, F Lefèvre-Borg, William Crumb, John A. Auchampach, S. Mondot, G J Gross, Henry H. Holzgrefe, R. Massingham, Joseph P. Buckley and M Mestre and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Icilio Cavero

192 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Icilio Cavero France 38 2.2k 1.9k 1.2k 1.0k 1.0k 193 4.8k
Norio Taira Japan 34 2.0k 0.9× 1.8k 1.0× 969 0.8× 958 0.9× 1.1k 1.1× 250 4.3k
Robert Ruffolo United States 48 3.1k 1.4× 1.9k 1.0× 1.9k 1.5× 593 0.6× 1.2k 1.2× 188 6.8k
J. R. Parratt United Kingdom 38 1.0k 0.5× 1.7k 0.9× 382 0.3× 1.5k 1.4× 972 1.0× 169 4.5k
Amanda Lochner South Africa 39 1.8k 0.8× 1.5k 0.8× 338 0.3× 1.6k 1.5× 1.2k 1.2× 187 5.3k
Morris Karmazyn Canada 51 4.2k 1.9× 2.9k 1.5× 461 0.4× 1.9k 1.9× 1.7k 1.7× 188 7.9k
W. G. Nayler Australia 34 1.6k 0.7× 2.1k 1.1× 534 0.4× 1.3k 1.3× 502 0.5× 139 3.9k
S. Jamal Mustafa United States 38 1.2k 0.6× 1.1k 0.6× 509 0.4× 514 0.5× 1.5k 1.5× 170 4.5k
Jun Feng United States 38 2.5k 1.1× 1.4k 0.8× 549 0.5× 995 1.0× 868 0.9× 261 6.5k
Julius Gy. Papp Hungary 38 2.4k 1.1× 3.4k 1.8× 631 0.5× 843 0.8× 379 0.4× 233 5.1k
Weizhong Zhu China 35 3.2k 1.4× 2.0k 1.1× 786 0.6× 574 0.6× 465 0.5× 85 4.5k

Countries citing papers authored by Icilio Cavero

Since Specialization
Citations

This map shows the geographic impact of Icilio Cavero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Icilio Cavero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Icilio Cavero more than expected).

Fields of papers citing papers by Icilio Cavero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Icilio Cavero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Icilio Cavero. The network helps show where Icilio Cavero may publish in the future.

Co-authorship network of co-authors of Icilio Cavero

This figure shows the co-authorship network connecting the top 25 collaborators of Icilio Cavero. A scholar is included among the top collaborators of Icilio Cavero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Icilio Cavero. Icilio Cavero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garay, Ricardo P., Leslie Citrome, George T. Grossberg, Icilio Cavero, & Pierre‐Michel Llorca. (2016). Investigational drugs for treating agitation in persons with dementia. Expert Opinion on Investigational Drugs. 25(8). 973–983. 24 indexed citations
2.
Cavero, Icilio & Henry H. Holzgrefe. (2016). 15th Annual Meeting of the Safety Pharmacology Society: Focus on traditional sensory systems. Journal of Pharmacological and Toxicological Methods. 83. 55–71. 2 indexed citations
3.
Cavero, Icilio & Henry H. Holzgrefe. (2014). Comprehensive in vitro Proarrhythmia Assay, a novel in vitro / in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative. Expert Opinion on Drug Safety. 13(6). 745–758. 73 indexed citations
4.
Cavero, Icilio. (2014). 13th Annual Meeting of the Safety Pharmacology Society: focus on novel technologies and safety pharmacology frontiers. Expert Opinion on Drug Safety. 13(9). 1271–1281. 16 indexed citations
5.
Cavero, Icilio. (2009). Safety Pharmacology Society: 8th annual meeting. Expert Opinion on Drug Safety. 8(2). 237–247. 10 indexed citations
6.
Holzgrefe, Henry H., Icilio Cavero, Lewis V. Buchanan, Michael Gill, & Stephen K. Durham. (2006). Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: Effects of moxifloxacin. Journal of Pharmacological and Toxicological Methods. 55(3). 244–254. 45 indexed citations
7.
Holzgrefe, Henry H., Icilio Cavero, Carol Gleason, et al.. (2006). Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods. 55(2). 159–175. 40 indexed citations
8.
Cavero, Icilio & William Crumb. (2005). ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis. Expert Opinion on Drug Safety. 4(3). 509–530. 55 indexed citations
9.
Cavero, Icilio, et al.. (2000). Frequency‐independent blockade of cardiac Na+channels by riluzole: comparison with established anticonvulsants and class I anti‐arrhythmics. Fundamental and Clinical Pharmacology. 14(2). 107–117. 18 indexed citations
10.
Cavero, Icilio, et al.. (1996). Pharmacological evidence that NK‐2 tachykinin receptors mediate hypotension in the guinea pig but not in the rat. Fundamental and Clinical Pharmacology. 10(4). 337–343. 5 indexed citations
11.
Floch, Anne, V. Fardin, & Icilio Cavero. (1994). Characterization of NK1 and NK2 tachykinin receptors in guinea‐pig and rat bronchopulmonary and vascular systems. British Journal of Pharmacology. 111(3). 759–768. 29 indexed citations
12.
Ferré, F., F. Mondon, Laurent Cronier, et al.. (1993). ヒト培養胎盤栄養膜におけるエンドセリン-1結合部位および免疫反応性 エンドセリン-1のオートクリンおよびパラクリン的役割を示す証拠. Journal of Cardiovascular Pharmacology. 22. 214–218. 1 indexed citations
13.
Floch, Anne, et al.. (1993). Evidence for NK-1 receptor subtypes from in vivo bronchopulmonary and cardiovascular studies. Regulatory Peptides. 46(1-2). 307–308. 5 indexed citations
15.
Auchampach, John A., Icilio Cavero, & Garrett J. Gross. (1992). Nicorandil Attenuates Myocardial Dysfunction Associated with Transient Ischemia by Opening ATP-Dependent Potassium Channels. Journal of Cardiovascular Pharmacology. 20(5). 765–771. 32 indexed citations
17.
Richer, C, et al.. (1990). Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sciences. 47(19). 1693–1705. 89 indexed citations
18.
Lawson, Kim & Icilio Cavero. (1989). (‐)‐BAY K 8644 LIBERATES A CONTRACTANT FACTOR FROM THE ENDOTHELIUM OF THE RAT AORTA. Fundamental and Clinical Pharmacology. 3(6). 687–693. 2 indexed citations
19.
Richer, Chantal, et al.. (1985). Nicardipine: action antihypertensive expérimentale et interaction avec le système sympathique alpha-adrénergique.. 16(1). 45–58. 2 indexed citations
20.
Cavero, Icilio, et al.. (1979). Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(3). 445P–445P. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026